Evidence map›Paper›PMID 36217094›Full record

ArticleAdvances in experimental medicine and biology2022

Innovations in the Treatment of Pediatric Obstructive Sleep Apnea.

Allan Damian, David Gozal

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Advances in experimental medicine and biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05621577 (Socio-Demographic - Dental & Respiratory Changes of Obstructive Sleep Apnea), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05621577 naunknown statusnot on this mapstarted 2023, after this paper: background citation

Socio-Demographic - Dental & Respiratory Changes of Obstructive Sleep Apnea (OSA) Patients Treated With Mandibular Advancement Device (MAD) of Samples in Erbil City

TypeinterventionalSponsorHawler Medical UniversityRan2023 to 2023Enrolled20ConditionsSleep Apnea, ObstructiveArmsMANDIBULAR ADVANCEMENT DEVICE
3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Allan DamianDepartment of Neurology, University of Missouri School of Medicine, Columbia, MO, USA.
David GozalComprehensive Sleep Medicine Program, University of Missouri School of Medicine, Columbia, MO, USA. gozald@health.missouri.edu.
SleepMed · USUniversity of Missouri · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obstructive sleep apnea affects a large proportion of otherwise healthy children in the context of interactions between craniofacial elements, adenotonsillar hypertrophy and other anatomical factors, and neuromuscular reflexes of the upper airway. In light of the adverse consequences of sleep apnea, it is important not only to proceed with early diagnosis but also to implement adequate treatment that is guided by the pathophysiological determinants of the disease in each child. Here, we will describe the current standard of care approaches to the treatment of pediatric obstructive sleep apnea, and will also explore novel management strategies that should enable more personalized therapy in the near future.

Indexed as

Sleep Apnea, ObstructiveSleep Apnea SyndromesTonsillectomyAdenoidectomyChildHumansHypertrophyAdenoidectomyAdenotonsillar hypertrophyAnti-inflammatoryBilevel PAPCPAPDietDISEHigh flow nasal cannulaIntra-oral appliancesLeukotriene receptor modifiersMandibular advancementMyofunctional therapyNasal corticosteroidsObesityOrthodonticsTonsillectomyWeigh management

Identifiers

PMID36217094
OpenAlexW4304481153

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.